cabergoline has been researched along with Delayed Effects, Prenatal Exposure in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernard, P; Hubinont, C; Lebbe, M; Maiter, D | 1 |
1 other study(ies) available for cabergoline and Delayed Effects, Prenatal Exposure
| Article | Year |
|---|---|
Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women.
Topics: Adult; Antineoplastic Agents; Cabergoline; Case-Control Studies; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Infant, Newborn; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Prolactinoma; Retrospective Studies | 2010 |